Immatics N.V. (IMTX) stock
IMTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.29+0.12 (+1.94%)
Close on Nov 17, 2026Market cap $843.31MP/E –Yield –
Immatics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Immatics's pe ratio was 62.5× on Feb 27, 2026, against 28.9× a year earlier. Over the last 2 years it ranged from 15.9× to 65.8×, with a median of 29.8×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Feb 27, 2026 | 62.5× | −1.4 |
| 2025 | Dec 31, 2025 | 63.9× | +35.0 |
| 2024 | Feb 29, 2024 | 28.9× | +5.1 |
| 2023 | Dec 29, 2023 | 23.8× | – |
See a number that looks wrong?